REG - IP Group PLC - Director Declaration

IPAnnouncement

31/10/2018 17:55

RNS Number : 9462F
IP Group PLC
31 October 2018
 





FOR RELEASE ON


31 October 2018



 
IP Group plc - Director declaration
 
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that Sir Douglas Flint, Non-executive Chairman, will be appointed as a Non-Executive Director and Chairman Designate of Standard Life Aberdeen plc from 1 November 2018.
 
This disclosure is made in accordance with LR 9.6.14R of the Listing Rules.
 
For more information, please contact:
 



IP Group plc


www.ipgroupplc.com




Alan Aubrey, Chief Executive Officer

Greg Smith, Chief Financial Officer

Liz Vaughan-Adams, Communications           


+44 (0) 20 7444 0050



+44 (0) 20 7444 0062/+44 (0) 7979 853802




Charlotte Street Partners








Andrew Wilson


+44 (0) 7810 636995




Martha Walsh


+44 (0) 7876 245962




Tom Gillingham


+44 (0) 7741 659021



 
Notes for editors
 
About IP Group
 
IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
 
For more information, please visit our website at www.ipgroupplc.com.
 
ENDS




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNFKDDPOBDDKKN